CVI_BlueLab2_edited_edited.jpg

The Cancer Vaccine Institute (CVI) at the University of Washington is a community of scientists, doctors, nurses, patients, and philanthropists creating a world where cancer can be managed, treated, and ultimately prevented by vaccines and immunotherapies.

 

We’ve disrupted the traditional lab model by connecting the early discovery, translational research, and clinical trial phase work under one roof. This approach brings our ground-breaking cancer immunology research out of the lab and into the lives of cancer patients faster, more efficiently, and with greater success.

Igniting the Immune System to End Cancer
 

Disruptive & Fearless

We're the largest academic organization in the US focused on developing vaccines that complement existing cancer treatments and prevent the disease from returning.

Precision Collaboration

Truly Life-Changing Results

We’ve assembled an unrivaled team of multidisciplinary scientists, medical professionals, and patients to turn our cutting-edge cancer immunology research into effective treatments for some of today’s most common and devastating types of cancer.

Over the past 20 years, the CVI has conducted over two dozen trials that use vaccines to complement existing treatments and reduce the risk of relapse.

$27 M

In grant funding

over the past 5 years

25

Phase I and Phase II

clinical trials

250

Scientific publications

15

Patents,

+7 more pending

CVI_FB5_blue_edited.jpg

For Patients

We’re creating a world where cancer is proactively and successfully cured — and we’re some of the foremost experts in the world. Our work focuses on cancers that have a major impact on communities today, and we have clinical trials in many types of cancers.

Our Research

We're one of the largest labs in the US, focused on developing multi-antigenic vaccines and other immune therapies. Our multidisciplinary team has over 30 members — trailblazers in the scientific and medical fields — uniquely focused on early discovery, translational research, and clinical trials, all under one roof.

Join Us

Together, we are outsmarting cancer. Though research has brought us advancements that have truly improved patients' lives, the number one limitation is funding. While our research would not be possible without grants, your support accelerates our creativity and innovation.

Leaders in the Field

20 years ago, Dr. Nora Disis had the groundbreaking idea that it’s possible to harness the immune system to identify, treat, and heal cancer — just like it would to fight off an infection. Today, the Cancer Vaccine Institute at University of Washington Medicine in Seattle, WA, is one of the few organizations that is tackling and connecting all three phases of the scientific process: early discovery, translational research, and clinical trial. Within the next 10 years, we expect that vaccines will be broadly available to revolutionize the way we treat and prevent cancers.

WHAT'S NEW AT THE CVI